Temozolomide (NSC 362856), DNA Alkylator
Por um escritor misterioso
Descrição
Temozolomide (NSC 362856) is an oral active DNA alkylating agent that crosses the blood-brain barrier. Temozolomide is also a proautophagic and proapoptotic agent. Temozolomide is effective against tumor cells that are characterized by low levels of O6-alkylguanine DNA alkyltransferase (OGAT) and a functional mismatch repair system. Temozolomide has antitumor and antiangiogenic effects. - Mechanism of Action & Protocol.
Biomedicines, Free Full-Text
Temozolomide (NSC 362856), DNA Alkylator
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules
Temozolomide, CAS 85622-93-1
Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy - ScienceDirect
Temozolomide CAS 85622-93-1 Manufacturers, Suppliers, Factory - Home Sunshine Pharma
Temozolomide
Temozolomide (NSC 362856), DNA Alkylator
Phase I and Pharmacokinetic Study of Temozolomide on a Daily-for-5-Days Schedule in Patients With Advanced Solid Malignancies
Temozolomide (NSC 362856), DNA Alkylator
Temozolomide, CAS:85622-93-1, DNA-methylating antitumor agent; also induces autophagy, High Purity
de
por adulto (o preço varia de acordo com o tamanho do grupo)
